anti-CD29 antibody product blog
Tags: Antibody; Monoclonal Antibody; CD29; anti-CD29 antibody;
The CD29 n/a (Catalog #MBS335382) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Mouse Anti-Human CD29 Monoclonal Antibody, Unconjugated Clone B-D15 reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CD29 can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS), Immunohistochemistry (IHC).Working Dilution: Use 10 mul to label 106 cells or 100 mul of whole blood. Researchers should empirically determine the suitability of the CD29 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CD29 n/a product has the following accession number(s) (GI #149227986) (NCBI Accession #ABR23000.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Mouse Anti-Human CD29 Monoclonal Antibody, Unconjugated Clone B-D15 with the following immunoassay(s):
Testing Data (A typical staining pattern with the B-D15 monoclonal antibody of lymphocytes)
Antigen: CD29
Hybridoma: Myeloma X63/AG.8653 x Balb/c spleen cells
Immunisation: U937 cell line. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD29 are readily searchable from our website. Different antibodies against the same target such as CD29 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene.